Paclitaxel Protein-bound Particles Injection, Powder, Lyophilized, For Suspension
Product Images NDC 69097-398

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Paclitaxel Protein-bound Particles (NDC 69097-398). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cipla Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (246854f7 9f4b 45f2 Aa64 D482a256bf56 01)

FDA Label Image

100ml Label (246854f7 9f4b 45f2 Aa64 D482a256bf56 02)

This text appears to be a description of a pharmaceutical product. It mentions an unvarnished area for batch overprinting of a medication called Paclitaxel, which is protein-bound particles for injectable suspension. The product is indicated for intravenous use only and provides functional properties different from other Paclitaxel products. It contains 100 mg per vial and is a single-dose vial to be discarded if not fully used. The manufacturer mentioned is Cipla. The text also includes some dosage and administration instructions.*

FDA Label Image

100ml-carton (246854f7 9f4b 45f2 Aa64 D482a256bf56 03)

FDA Label Image

Image (246854f7 9f4b 45f2 Aa64 D482a256bf56 164 2)

FDA Label Image

Image (246854f7 9f4b 45f2 Aa64 D482a256bf56 233 1)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.